From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany

Barbara Gunsenheimer‐Bartmeyer(Robert Koch Institute), Carlos Fritzsche(Robert Koch Institute), Andreas Plettenberg(Institute for Interdisciplinary Medicine), Johannes R. Bogner(Klinik und Poliklinik für Orthopädie, Physikalische Medizin und Rehabilitation), Heinz‐August Horst(Goethe University Frankfurt), A Kühne(Robert Koch Institute), Daniel Schmidt(Robert Koch Institute), Björn‐Erik Ole Jensen(Düsseldorf University Hospital), Jürgen K. Rockstroh(University of Bonn), Gerd Fätkenheuer(University of Cologne), Christian Kollan(Robert Koch Institute), Stefan Eßer(Essen University Hospital), Frank Bergmann(München Klinik), Jan van Lunzen(Universidade Federal de São Paulo), Osamah Hamouda, Matthias Stoll(Medizinische Hochschule Hannover), Matthias an der Heiden(Robert Koch Institute), Hans‐Jürgen Stellbrink
BMC Public Health
March 16, 2015
10.1186/s12889-015-1598-4
Cited by 18

Related Papers

Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by <i>Staphylococcus aureus</i>
|New England Journal of Medicine|2006|1.5k
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Epidemic Profile of Shiga-Toxin–Producing<i>Escherichia coli</i>O104:H4 Outbreak in Germany
|New England Journal of Medicine|2011|1.1k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
German Outbreak of<i>Escherichia coli</i>O104:H4 Associated with Sprouts
|New England Journal of Medicine|2011|718